Vendome Acquisition CORP I

Market Movers (8-K)

NASDAQ
Vendome Acquisition Corporation I announced that its Class A ordinary shares and warrants will commence separate trading on Nasdaq from August 22, 2025.
NASDAQ
Vendome Acquisition Corporation I, a blank check company, successfully completed its initial public offering of 20 million units at $10.00 per unit, raising $200 million, alongside a $2.648 million private placement, with the majority of proceeds placed into a trust account for a future business combination.
Capital raise
NASDAQ
Vendome Acquisition Corporation I has successfully priced its initial public offering of 20 million units at $10.00 per unit, raising $200 million, and plans to seek a business combination in the consumer sector within 24 months.
Capital raise

Quarterly Earnings (10-Q)

NASDAQ
Vendome Acquisition Corporation I, a blank check company, reported its third-quarter 2025 results, highlighting its ongoing search for a business combination and significant trust account balance.
Capital raise
NASDAQ
Vendome Acquisition Corporation I, a blank check company, filed its Q2 2025 report, detailing its financial position prior to its $200 million initial public offering and private placement completed in July 2025.
Capital raise
NASDAQ
Vendome Acquisition Corporation I, a blank check company, filed its first quarterly report detailing its financial position as of March 31, 2025, and subsequent completion of its Initial Public Offering.
Capital raise

Annual Reports (10-K)

NASDAQ
Vendome Acquisition Corporation I, a blank check company, filed its annual 10-K report for fiscal year 2025, detailing its formation, initial public offering, and ongoing search for a business combination target.
Capital raise

New Public Companies (S-1)

NASDAQ
Vendome Acquisition Corporation I, a special purpose acquisition company, filed an amended S-1 registration statement detailing its planned $200 million initial public offering of 20 million units, each comprising one Class A ordinary share and half a warrant, alongside a private placement and robust corporate governance provisions.
Capital raise
NASDAQ
Vendome Acquisition Corporation I, a newly formed blank check company, has filed an amended S-1 registration statement for its initial public offering of 20 million units at $10.00 per unit, aiming to raise $200 million to fund a business combination within 24 months.
Capital raise
NASDAQ
Vendome Acquisition Corporation I, a newly formed blank check company, has filed an amended S-1 registration statement for its initial public offering of 20 million units at $10.00 each, aiming to raise $200 million for a future business combination while disclosing substantial dilution risks for public shareholders.
Capital raise
NASDAQ
Vendome Acquisition Corporation I, a newly formed blank check company, aims to raise $150 million through an initial public offering to pursue a business combination in the consumer sector.
Capital raise

Schedule 13G - Passive Investments

NASDAQ
First Trust Capital Management and associated entities have filed a Schedule 13G/A reporting a 5.46% beneficial ownership stake in Vendome Acquisition Corp I.
NASDAQ
Meteora Capital, LLC and Vik Mittal have reported beneficial ownership of 9.99% of Vendome Acquisition Corp I's Class A common stock as of March 31, 2026.
NASDAQ
Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of over 5% of Vendome Acquisition Corporation I's Class A ordinary shares.
NASDAQ
Meteora Capital, LLC and its managing member, Vik Mittal, have disclosed a 9.99% beneficial ownership stake in Vendome Acquisition Corp I's Class A common stock.
NASDAQ
Barclays PLC has filed an amended Schedule 13G, reporting beneficial ownership of 450 common shares, representing 0.00% of Vendome Acquisition Corp-A.
NASDAQ
First Trust Merger Arbitrage Fund and related entities have disclosed beneficial ownership of up to 9.25% of Vendome Acquisition Corp I's Class A Ordinary Shares.